- Home
- WWR vs PMN Comparison
WWR vs PMN Comparison
Compare WWR & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WWR | PMN |
|---|---|---|
| Founded | 1977 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Metal Mining | Pharmaceuticals and Biotechnology |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.8M | 23.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WWR | PMN |
|---|---|---|
| Price | $0.99 | $8.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $1.88 | ★ $72.67 |
| AVG Volume (30 Days) | ★ 2.1M | 43.4K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.45 | $6.27 |
| 52 Week High | $3.75 | $39.75 |
Technical Indicators
Market Signals| Indicator | WWR | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 88.71 |
| Support Level | $0.95 | $7.35 |
| Resistance Level | $1.09 | $9.26 |
| Average True Range (ATR) | 0.10 | 0.60 |
| MACD | 0.03 | 0.43 |
| Stochastic Oscillator | 44.97 | 96.99 |
Price Performance
Historical ComparisonAbout WWR Westwater Resources Inc.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.